The FDA announced it has commenced daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS ...

The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...

Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a ...

The FDA will now publish adverse event data from FAERS on a daily basis, marking a major step toward greater transparency in drug development.

The U.S. Food and Drug Administration (USFDA) has suspended the biologics license of Ixchiq (Chikungunya Vaccine, Live), ...

The FDA has started reporting real-time data about adverse events through the FDA Adverse Event Reporting System, improving ...

The U.S. Food and Drug Administration has started "real-time reporting of adverse event data," according to an annoucement ...

The agency said it had become aware of more reports of serious adverse events, leading center director Vinay Prasad to ...

In patients with active lupus nephritis, iscalimab shows efficacy in reducing proteinuria and is generally well tolerated.

Seltorexant is safe and more effective than placebo and a standard insomnia med for sleep initiation and maintenance, a new ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

The US Food and Drug Administration (FDA) began daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS). This represents a significant step forward in modernizing ...